PIONEER III Trial to Assess Safety and Efficacy of the BuMA Supreme™ Drug Coated Coronary Stent in Patients With Coronary Disease

NAActive, not recruitingINTERVENTIONAL
Enrollment

1,632

Participants

Timeline

Start Date

October 13, 2017

Primary Completion Date

October 1, 2020

Study Completion Date

September 30, 2024

Conditions
Coronary Artery Disease
Interventions
DEVICE

BuMA Supreme DES

Implant BuMA Supreme stent only

DEVICE

Xience or Promus DES

Implant XIENCE family or Promus family only

Trial Locations (58)

1211

University Hospital Geneva HUG, Clinic for Cardiology, Geneva

2820

Imelda, Bonheiden

3010

Inselspital, Universitätsspital Bern, Bern

3500

Jessa Hospital, Hasselt

3600

Ziekenhuis Oost Limburg Genk, Genk

10032

Columbia University Medical Center / New York Presbyterian Hospital, New York

17822

Geisinger Clinic, Danville

18901

Doylestown Hospital, Doylestown

19610

Berks Cardiologists, Ltd., Wyomissing

20010

Medstar Washington HWospital Center, Washington D.C.

21218

Medstar Union Memorial Hospital, Baltimore

22601

Winchester Medical Center, Winchester

22908

University of Virginia Health System, Charlottesville

27607

NC Heart and Vascular Research, Raleigh

29621

AnMed Health, Anderson

30322

Emory University Hospital, Atlanta

32401

Cardiovascular Institute of Northwest Florida, Panama City

33435

Bethesda Hospital East/Daniel Heart and Vascular Center, Boynton Beach

33613

Florida Hospital Tampa, Tampa

33756

Clearwater Cardiovascular Consultants, Clearwater

34471

MediQuest Research Group Inc., Ocala

35211

Cardiology, PC, Birmingham

36312

Hospital Álvaro Cunqueiro, Vigo

38801

North MS Medical Center, Tupelo

40241

Norton Brownsboro Hospital, Louisville

43608

Mercy St. Vincent Medical Center, Toledo

43701

Genesis Hospital, Zanesville

44035

North Ohio Heart, Elyria

44710

Aultman Hospital, Canton

45219

Lindner Research Center, Cincinnati

45429

Kettering Medical Center, Kettering

46202

Krannert Institute of Cardiology, Indianapolis

46290

St. Vincent's Medical Group, Indianapolis

48073

William Beaumont Hospital, Royal Oak

48197

Michigan Heart, Ypsilanti

49770

Northern Michigan Hospital d.b.a. McLaren Northern Michigan, Petoskey

50314

Iowa Heart Center, Des Moines

55805

Essential Health, Duluth

68124

CHI Health Research Center, Omaha

75701

Tyler Cardiovascular Consultants, Tyler

85297

Dignity Health - Mercy Gilbert Medical Center / Chandler Regional Medical Center, Gilbert

90048

Smidt Heart Institute Cedars-Sinai Maedical Center, Los Angeles

98122

Swedish Medical Center, Seattle

06520

Yale University, New Haven

08035

Cardiovascular Associates of Delaware Valley, Haddon Heights

02903

Rhode Island Hospital, Providence

Unknown

CHU Charleroi, Charleroi

Amsterdam UMC, Amsterdam

MCL, Leeuwarden

Maasstad Ziekenhuis, Rotterdam

Hospital Clinic de Barcelona, Barcelona

Hospital Universitari de Bellvitge, Barcelona

Hospital Ramon y Cajal, Madrid

Instituto de Investigación Hospital 12 de Octubre, Madrid

St Bartholomew's Hospital, London

T2N-2T9

Foothills Medical Centre, Calgary

M5B-1W8

St. Michael's Hospital, Toronto

247-8533

Shonan Kamakura General Hospital, Kanagawa

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Nova Vascular LLC

UNKNOWN

lead

Sino Medical Sciences Technology Inc.

INDUSTRY

NCT03168776 - PIONEER III Trial to Assess Safety and Efficacy of the BuMA Supreme™ Drug Coated Coronary Stent in Patients With Coronary Disease | Biotech Hunter | Biotech Hunter